Kevin Jason Murray

Kevin Jason Murray

Auto-generated profile, based on publicly available information

Kevin Jason Murray

Center for Metabolomics and Proteomics, Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, Minnesota

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2021 in Analytical Chemistry
Verified
Journal Article
Closed access
KMKevin J. Murray
Kevin J. Murray
ECErik Carlson
Erik Carlson
ASAlessia Stornetta
Alessia Stornetta
EBEmily P. Balskus
Emily P. Balskus
PVPeter Villalta
Peter Villalta
SBSilvia Balbo
Silvia Balbo

10 November 2022 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
RDRomel Dator
Romel Dator
KMKevin J. Murray
Kevin J. Murray
MLMatthew W. Luedtke
Matthew W. Luedtke
FJFoster C. Jacobs
Foster C. Jacobs
FKFekadu Kassie
Fekadu Kassie
SBSilvia Balbo
Silvia Balbo

20 October 2023 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
KMKevin J. Murray
Kevin J. Murray
PVPeter Villalta
Peter Villalta
TGTim J Griffin
Tim J Griffin
SBSilvia Balbo
Silvia Balbo

6 April 2024 in npj Metabolic Health and Disease
Verified
Journal Article
Open access
PDF file
ABAngela S. Bruzina
Angela S. Bruzina
CRChristiana J. Raymond-Pope
Christiana J. Raymond-Pope
KMKevin J. Murray
Kevin J. Murray
TLThomas J. Lillquist
Thomas J. Lillquist
KCKatelyn M. Castelli
Katelyn M. Castelli
SGSarah M. Greising
Sarah M. Greising
Following traumatic musculoskeletal injuries, prolonged bedrest and loss of physical activity may limit muscle plasticity and drive metabolic dysfunction. One specific injury, volumetric muscle loss (VML), results in frank loss of muscle and is characterized by whole-body and cellular metabolic dysfunction. However, how VML and restricted physical activity limit plasticity of the whole-body, cellular, and metabolomic environment of the remaining uninjured muscle remains unclear. Adult mice were randomized to posterior hindlimb compartment VML or were age-matched injury naïve controls, then randomized to standard or restricted activity cages for 8-wks. Activity restriction in naïve mice resulted in ~5% greater respiratory exchange ratio (RER); combined with VML, carbohydrate oxidation was ~23% greater than VML alone, but lipid oxidation was largely unchanged. Activity restriction combined with VML increased whole-body carbohydrate usage. Together there was a greater pACC:ACC ratio in the muscle remaining, which may contribute to decreased fatty acid synthesis. Further, β-HAD activity normalized to mitochondrial content was decreased following VML, suggesting a diminished capacity to oxidize fatty acids. The muscle metabolome was not altered by the restriction of physical activity. The combination of VML and activity restriction resulted in similar ( ~ 91%) up- and down-regulated metabolites and/or ratios, suggesting that VML injury alone is regulating changes in the metabolome. Data supports possible VML-induced alterations in fatty acid metabolism are exacerbated by activity restriction. Collectively, this work adds to the sequalae of VML injury, exhausting the ability of the muscle remaining to oxidize fatty acids resulting in a possible accumulation of triglycerides.

14 August 2023 in Aging
Verified
Journal Article
Open access
PDF file
MPMina P. Peyton
Mina P. Peyton
TYTzu-Yi Yang
Tzu-Yi Yang
LHLeeAnn Higgins
LeeAnn Higgins
TMTodd W. Markowski
Todd W. Markowski
KMKevin Murray
Kevin Murray
DLDawn A. Lowe
Dawn A. Lowe
The loss of skeletal muscle strength mid-life in females is associated with the decline of estrogen. Here, we questioned how estrogen deficiency might impact the overall skeletal muscle phosphoproteome after contraction, as force production induces phosphorylation of several muscle proteins. Phosphoproteomic analyses of the tibialis anterior muscle after contraction in two mouse models of estrogen deficiency, ovariectomy (Ovariectomized (Ovx) vs. Sham) and natural aging-induced ovarian senescence (Older Adult (OA) vs. Young Adult (YA)), identified a total of 2,593 and 3,507 phosphopeptides in Ovx/Sham and OA/YA datasets, respectively. Further analysis of estrogen deficiency-associated proteins and phosphosites identified 66 proteins and 21 phosphosites from both datasets. Of these, 4 estrogen deficiency-associated proteins and 4 estrogen deficiency-associated phosphosites were significant and differentially phosphorylated or regulated, respectively. Comparative analyses between Ovx/Sham and OA/YA using Ingenuity Pathway Analysis (IPA) found parallel patterns of inhibition and activation across IPA-defined canonical signaling pathways and physiological functional analysis, which were similarly observed in downstream GO, KEGG, and Reactome pathway overrepresentation analysis pertaining to muscle structural integrity and contraction, including AMPK and calcium signaling. IPA Upstream regulator analysis identified MAPK1 and PRKACA as candidate kinases and calcineurin as a candidate phosphatase sensitive to estrogen. Our findings highlight key molecular signatures and pathways in contracted muscle suggesting that the similarities identified across both datasets could elucidate molecular mechanisms that may contribute to skeletal muscle strength loss due to estrogen deficiency.

11 March 2025 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
KMKevin J. Murray
Kevin J. Murray
DMDylan Mckeon
Dylan Mckeon
CLChiara Lecchi
Chiara Lecchi
LMLaura Maertens
Laura Maertens
PVPeter Villalta
Peter Villalta
SBSilvia Balbo
Silvia Balbo